Research Article
Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer
Table 2
Pathologic partial and complete response rates: neoadjuvant chemotherapy.
| |||||||||||||||||||||||||||||||||||||||||||
Adjusted for age, gender, race, clinical stage, prior BCG use, extent of TUR, cardiac disease, and baseline creatinine. |